Smoking and cardio -vascular risk factors
https://doi.org/10.17802/2306-1278-2016-1-51-54
Abstract
In this review the literature data of 2010–2015 years were analysed for smoking prevalence and its influence on brain, heart, blood vessels, blood and treatment effects with taking into account of age, gender, genetic factors, duration of smoking. The results of smoking stopping and its biorhytmic aspects were presented too.
About the Authors
N. A. BARBARASH
State Budgetary Educational Institution of Higher Professional Education Kemerovo State Medical Academy Ministries of Health of the Russian Federation, Kemerovo, Russia
Russian Federation
Russian Federation
22A, Voroshilova st., Kemerovo, 650029, Russian Federation Tel. +7 (3842) 73-29-84
D. Yu. KUVSHINOV
State Budgetary Educational Institution of Higher Professional Education Kemerovo State Medical Academy Ministries of Health of the Russian Federation, Kemerovo, Russia
Russian Federation
Russian Federation
References
1. Болезни сердца и сосудов. Руководство Европейского общества кардиологов. Под ред. А. Д. Кэмма, Т. Ф. Люшера, П. В. Сердиуса. М.: ГЕОТАР-Медиа; 2011. Bolezni serdtsa i sosudov. Rukovodstvo Evropeyskogo obshchestva kardiologov. Pod red. A. D. Kemma, T. F. Lyushera, P. V. Serdiusa. Moscow; 2011. [In Russ].
2. Болезни сердца по Браунвальду. Том 1. Руководство по сердечно-сосудистой медицине. Под ред. П. Либби, Р. О. Боноу, Д. Л. Манна, Д. П. Зайпа. М.: Рид Этсивер; 2010. Bolezni serdtsa po Braunval’du. Tom 1. Rukovodstvo po serdechno-sosudistoy meditsine. pod red. P. Libbi, R. O. Bonou, D. L. Manna, D. P. Zaypa. Moscow, 2010. [In Russ].
3. Барбараш Н. А., Барбараш О . Л ., Завырылина И . Н. Курение и сердечно-сосудистая система. Кардиосоматика. 2013; 1: 44–47. Barbarash N. A., Barbarash O. L., Zavyrylina I. N. Kurenie i serdechno-sosudistaya sistema. Kardiosomatika. 2013; 1: 44–47. [In Russ].
4. Леонова М. В. Влияние курения на эффективность кардиоваскулярных препаратов. Consilium Medicum (Кардиология). 2013; 1: 27. Leonova M. V. Vliyanie kureniya na effektivnost’ kardiovaskulyarnykh preparatov. Consilium Medicum (Kardiologiya). 2013; 1: 27. [In Russ].
5. Оганов Р . Г ., Масленникова Г . Я . Достижения и неудачи в профилактике сердечно-сосудистых заболеваний. Кардиоваскулярная терапия и профилактика. 2014; 13 (1): 4–7. Oganov R. G., Maslennikova G. Ya. Dostizheniya i neudachi v profilaktike serdechno-sosudistykh zabolevaniy. Kardiovaskulyarnaya terapiya i profilaktika. 2014; 13 (1): 4–7. [In Russ].
6. Перминов А. А., Кувшинов Д. Ю., Барбараш Н. А. Индивидуальный год и курение юношей. Germany, Saarbrüсken: Lambert Academic Publishing, 2011. Perminov A. A., Kuvshinov D. Yu., Barbarash N. A. Individual’nyy god i kurenie yunoshey. Germany, Saarbrüsken: Lambert Academic Publishing, 2011. [In Russ].
7. Баланова Ю. А., Концевая А. В., Шальнова С. А., Деев А. Д., Артамонова Г . В., Гатагонова Т. М. Распространённость поведенческих факторов риска сердечно-сосудистых заболеваний в российской популяции по результатам исследования ЭССЕ-РФ. Профилактическая медицина. 2014; 5: 42–52. Balanova Yu. A., Kontsevaya A. V., Shal’nova S. A., Deev A. D., Artamonova G. V., Gatagonova T. M. Rasprostranennost’ povedencheskikh faktorov riska serdechno-sosudistykh zabolevaniy v rossiyskoy populyatsii po rezul’tatam issledovaniya ESSE-RF. Profilakticheskaya meditsina. 2014; 5: 42–52. [In Russ].
8. Цыганкова О . В., Николаев К . Ю., Федорова Е . Л ., Бондарева З . Г ., Рагино Ю. И ., Платонов Д. Ю. Факторы риска сердечно-сосудистых заболеваний. Взгляд на женщину. Атеросклероз. 2014; 10 (1): 44–55. Tsygankova O. V., Nikolaev K. Yu., Fedorova E. L., Bondareva Z. G., Ragino Yu. I., Platonov D. Yu. Faktory riska serdechno- sosudistykh zabolevaniy. Vzglyad na zhenshchinu. Ateroskleroz. 2014; 10 (1): 44–55. [In Russ].
9. Jensen K. P., DeVito E. E., Herman A. I., Valentine G. W., Gelernter J., Sofuoglu M. A CHRNA5 smoking risk variant decreases the aversive effects of nicotine in humans. Neuropsychopharmacology.2015; 40: 2813–2821. DOI: 10.1038/npp.2015.131.
10. Kang S. J., Mintz G. S., Witzenbichler B., Metzger D. C., Rinaldi M. J., Duffy P. L. Age-related effects of smoking on culprit lesion plaque vulnerability as assessed by grayscale and virtual histology-intravascular ultrasound. Coron. Artery Dis. 2015; 26 (6): 476–483.
11. Kang S. J., Mintz G. S., Weisz G., Mehran R., Rabbani L. E., Verheye S. Age-related effects of smoking on coronary artery disease assessed by gray scale and virtual histology intravascular ultrasound. Am. J. Cardiol. 2015; 115 (8): 1056–1062. DOI: 10.1016/j.amjcard.2015.01.535.
12. Du H., Dong C. Y., Lin Q. Y. Risk factors of acute myocardial infarction in middle-aged and adolescent people (<45 years) in Yantai. BMC Cardiovasc. Disord. 2015; 15 (1): 106.
13. Lippi G., Favaloro E. J., Meschi T., Mattiuzzi C., Borghi L., Cervellin G. E-cigarettes and cardiovascular risk: beyond science and mysticism. Semin. Thromb. Hemost. 2014; 40 (1): 60–65.
14. Chomistek A. K., Chiuve S. E., Eliassen A. H. et al. Healthy lifestyle in the primordial prevention of cardiovascular disease among young women. J. Am. Coll. Cardiol. 2015; 65 (1): 43–51. DOI: 10.1016/j.jacc.2014.10.024.
15. Miyazaki T., Ashikaga T., Ohigashi H., Komura M., Kobayashi K., Isobe M. Impact of smoking on coronary microcirculatory resistance in patients with coronary artery disease. Int. Heart J. 2015; 56 (1): 29–36. DOI: 10.1536/ihj.14-189.
16. Lee M. H., Park J. J., Yoon C. H., Cha M. J., Park S. D., Oh I. Y. et al. Impact of smoking status on clinical outcomes after successful chroni total occlusion intervention: Korean national registry of CTO intervention. Catheter Cardiovasc. Interv. 2015; Sep. 2. DOI: 10.1002/ccd.26167. [Epub ahead of print].
17. Cagirci G., Cay S., Karakurt O., Eryasar N., Kaya V., Canga A. et al. Influence of heavy cigarette smoking on heart rate variability and heart rate turbulence parameters. Ann. Noninvasive Electrocardiol. 2009; 14 (4): 327–332.
18. Koh H. K., Sebelius K. G. Ending the tobacco epidemie. JAMA. 2012; 309: 2087.
19. Leone A. Toxics of tobacco smoke and cardiovascular system: From functional to cellular damage. Curr. Pharm. Des. 2015; 21 (30): 4370–4379.
20. Girard D., Delgado-Eckert E., Schaffner E. et al. Longterm smoking cessation and heart rate dynamics in an aging healthy cohort: Is it possible to fully recover? Environ Res. 2015; 143 (Pt. A): 39–48.
21. Muraira-Cárdenas L. C., Gutiérrez-Dolores M. Effects of chronic smoking on the superior mesenteric artery (SMA). Gac. Med. Mex. 2015; 151 (3): 294–298.
22. Hamer M., Stamatakis E., Kivimaki M. et al. Objectively measured secondhand smoke exposure and risk of cardiovascular disease: what is the mediating role of inflammatory and hemostatic factors? J. Am. Coll. Cardiol. 2010; 56 (1): 18–23. DOI:10.1016/j.jacc.2010.03.032.
23. Delgado G. E., Siekmeier R., Kramer B. K., Marz W., Kleber M. E. Plasma fibrinolysis parameters in smokers and non-smokers of the Ludwigshafen Risk and Cardiovascular Health (LURIC) Study. Adv. Exp. Med. Biol. 2015; 858: 69–77.
24. Pan A., Wang Y., Talaei M., Hu F. B. Relation of smoking with total mortality and cardiovascular events among patients with diabetes: a meta-analysis and systematic review. Circulation. 2015; 132 (19): 1795–804. DOI: 10.1161/CIRCULATIONAHA. 115.01792.
25. Adams T., Wan E., Wei Yi., Wahab R., Castagna F., Wang G. et al. Secondhand smoking is associated with vascular inflammation. Chest. 2015; 148 (1): 112–119. DOI: 10.1378/chest.14-2045.
26. Miyata S., Noda A., Ito Y., Iizuka R., Shimokata K. Smoking acutely impaired endothelial function in healthy college students. ActaCardiol. 2015; 70 (3): 282–285. DOI: 10.2143/ AC.70.3.3080632.
27. Gupta R., Gupta N., Khedar R. S. Smokeless tobacco and cardiovascular disease in low and middle income countries. Indian Heart J. 2013; 65 (4): 369–377.
28. Krajcoviechova A., Wohlfahrt P., Mayer O., Vaněk J., Hajkova J., Hlinovsky D. Tobacco smoking strongly modifies the association of prothrombin G20210A with undetermined stroke: consecutive survivors and population-based controls. Atherosclerosis. 2015; 240 (2): 446–452. DOI: 10.1016/j.atherosclerosis.2015.04.010.
29. Uoyd-Jones D. M. Сardiovascular health and protection against CVD. More than the sum of the parts? Circulation. 2014; 30: 1671–1673.
30. Kaufmann R. B., Babb S., O’Halloran A., Asman K., Bishop E., Tynan M. et al. Vital signs: nonsmokers exposure to secondhand smoke – United states 1998–2008. JAMA. 2010; 304: 1892–1894.
31. Oberg M., Jaakkola M. S., Woodward A., Peruga A., Prüss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011; 377: 139–146. DOI: http://dx.doi.org/10.1016/S0140-6736(10)61388-8.
32. Wipfli H. L., Samet J. M. Second-hand smoke’s worldwide disease toll. Lancet. 2011; 377: 101–102.
Review
For citations:
BARBARASH N.A., KUVSHINOV D.Yu. Smoking and cardio -vascular risk factors. Complex Issues of Cardiovascular Diseases. 2016;(1):51-54. (In Russ.) https://doi.org/10.17802/2306-1278-2016-1-51-54
Views:
1048
